South Korea’s Quest for a Blockbuster Drug: The Rise of ADCs in the K-Bio Landscape
[su_note note_color=”#f8f8f0″ radius=”7″]The pharmaceutical industry is on the cusp of a revolution with the advent of Antibody-Drug Conjugates (ADCs), hailed as the next frontier in cancer therapy. These innovative drugs combine the specificity of antibodies with the potency of chemotherapy, promising a targeted attack on cancer cells while sparing healthy tissues. South Korea, a burgeoning … Read more